Insider Trading May 12, 2026 04:48 PM

JELD-WEN Director Executes Stock Sale Amidst Recent Earnings Volatility

Bruce M. Taten disposes of 19,483 shares to manage tax obligations following restricted stock unit vesting.

By Maya Rios JELD

A recent regulatory filing reveals that Bruce M. Taten, a member of the board of directors at JELD-WEN Holding, Inc. (NYSE:JELD), has completed a sale of company common stock. The transaction occurred on May 11, 2026, involving 19,483 shares sold at a price of $1.6568 per share, resulting in total proceeds of $32,279. This divestment follows the vesting of a restricted stock unit grant that was initially issued to Mr. Taten on May 8, 2025. The sale was specifically executed to address tax liabilities linked to that vesting event. Following this move, Mr. Taten maintains a direct holding of 88,158 shares of JELD-WEN common stock.

JELD-WEN Director Executes Stock Sale Amidst Recent Earnings Volatility
JELD

Key Points

  • Director Bruce M. Taten sold shares to cover tax liabilities following RSU vesting.
  • JELD-WEN reported a significant EPS miss of 72.41% despite a slight revenue beat.
  • The stock is currently trading significantly lower than its 52-week highs but shows potential upside based on fair value estimates.

JELD-WEN Holding, Inc. (NYSE:JELD) has seen recent insider activity as director Bruce M. Taten sold 19,483 shares of the company's common stock on May 11, 2026. The transaction, which totaled $32,279, was conducted at a share price of $1.6568. According to the details of the filing, this sale was intended to cover tax obligations arising from the vesting of restricted stock units that were granted on May 8, 2025. Despite this transaction, Mr. Taten continues to hold 88,158 shares of JELD-WEN directly.



Market Context and Financial Performance

The stock sale occurs during a period of significant price movement for JELD-WEN. Over the previous year, JELD shares have experienced a decline of 63%, with recent trading seen at $1.57, which is positioned near its 52-week low of $0.93. While current market pricing reflects this downward trend, some analytical models suggest an undervaluation; specifically, InvestingPro analysis identifies a Fair Value of $2.03, indicating potential upside for the stock.

This insider transaction follows a period of financial pressure highlighted in JELD-WEN's first-quarter 2026 earnings report. The company reported a challenging quarter with earnings per share (EPS) of -$0.50. This figure fell short of the anticipated -$0.29 from analysts, representing a negative surprise of 72.41%. On a brighter note, revenue for the quarter reached $722 million, which slightly surpassed the forecasted $720.81 million.



Key Analytical Points

  • Insider Tax Management: The sale by Bruce M. Taten was not characterized as a discretionary market trade but rather a move to satisfy tax requirements related to the vesting of restricted stock units from May 2025.
  • Divergent Financial Indicators: There is a notable tension between the company's earnings performance and its revenue generation, as JELD-WEN beat revenue expectations while significantly missing EPS targets.
  • Valuation Discrepancy: The current trading price of $1.57 sits in contrast to a calculated Fair Value of $2.03, highlighting a gap between recent market performance and intrinsic valuation estimates.


Risks and Uncertainties

  • Debt Burden: A significant risk factor identified for JELD-WEN is its substantial debt load, which remains a critical component of the company's financial profile.
  • Earnings Volatility: The large negative surprise in EPS (72.41%) underscores the difficulty the company faces in meeting analyst expectations amidst current market headwinds.
  • Price Momentum: With the stock trading near its 52-week low and having lost 63% of its value over the last year, the downward momentum presents a continuous challenge for stakeholders.

Risks

  • High debt levels impacting the balance sheet.
  • Substantial earnings misses relative to analyst forecasts.
  • Significant year-over-year stock price decline of 63%.

More from Insider Trading

Edwards Lifesciences CEO Executes Multi-Million Dollar Share Sale via Pre-Set Trading Plan May 12, 2026 Covista CFO Executes $1.26 Million Stock Sale via Pre-Scheduled Trading Plan May 12, 2026 Covista Executive Executes Planned Share Sale Amidst Corporate Growth and Financial Restructuring May 12, 2026 Covista Executive Executes $1.22 Million Stock Sale Under Pre-Planned Trading Program May 12, 2026 Ameriprise Financial Director Executes Stock Sale Amid Strong Earnings Performance May 12, 2026